 | • レポートコード：B-GIR09D1264 • 出版社/出版日：GlobalInfoResearch / 2019年9月4日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、エポプロステノールナトリウム薬の世界市場について調べ、まとめました。種類別セグメントは、0.5 mg、1.5 mg等、用途別セグメントは、病院、クリニック等に区分しました。エポプロステノールナトリウム薬の世界市場概観、メーカー動向、メーカー別エポプロステノールナトリウム薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エポプロステノールナトリウム薬の市場概観 ・エポプロステノールナトリウム薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エポプロステノールナトリウム薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・エポプロステノールナトリウム薬の世界市場規模 ・エポプロステノールナトリウム薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・エポプロステノールナトリウム薬のアメリカ市場規模推移 ・エポプロステノールナトリウム薬のカナダ市場規模推移 ・エポプロステノールナトリウム薬のメキシコ市場規模推移 ・エポプロステノールナトリウム薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・エポプロステノールナトリウム薬のドイツ市場規模推移 ・エポプロステノールナトリウム薬のイギリス市場規模推移 ・エポプロステノールナトリウム薬のロシア市場規模推移 ・エポプロステノールナトリウム薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・エポプロステノールナトリウム薬の日本市場規模推移 ・エポプロステノールナトリウム薬の中国市場規模推移 ・エポプロステノールナトリウム薬の韓国市場規模推移 ・エポプロステノールナトリウム薬のインド市場規模推移 ・エポプロステノールナトリウム薬の東南アジア市場規模推移 ・エポプロステノールナトリウム薬の南米市場分析（ブラジル、アルゼンチン等） ・エポプロステノールナトリウム薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・エポプロステノールナトリウム薬の種類別分析/販売量、売上、市場シェア（0.5 mg、1.5 mg） ・エポプロステノールナトリウム薬の用途別分析/市場規模（病院、クリニック） ・エポプロステノールナトリウム薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・エポプロステノールナトリウム薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation.
Scope of the Report:
The worldwide market for Epoprostenol Sodium Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Epoprostenol Sodium Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
GSK
Teva
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
0.5 mg
1.5 mg
Market Segment by Applications, can be divided into
Hospital
Clinic
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Epoprostenol Sodium Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Epoprostenol Sodium Drugs, with price, sales, revenue and global market share of Epoprostenol Sodium Drugs in 2017 and 2018.
Chapter 3, the Epoprostenol Sodium Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Epoprostenol Sodium Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Epoprostenol Sodium Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Epoprostenol Sodium Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Epoprostenol Sodium Drugs Introduction
1.2 Market Analysis by Type
1.2.1 0.5 mg
1.2.2 1.5 mg
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Epoprostenol Sodium Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Epoprostenol Sodium Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Teva
2.2.1 Business Overview
2.2.2 Epoprostenol Sodium Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Teva Epoprostenol Sodium Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Epoprostenol Sodium Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Epoprostenol Sodium Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Epoprostenol Sodium Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Epoprostenol Sodium Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Epoprostenol Sodium Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Epoprostenol Sodium Drugs Market Analysis by Regions
4.1 Global Epoprostenol Sodium Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Epoprostenol Sodium Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Epoprostenol Sodium Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
4.5 South America Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
5 North America Epoprostenol Sodium Drugs by Country
5.1 North America Epoprostenol Sodium Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Epoprostenol Sodium Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Epoprostenol Sodium Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
6 Europe Epoprostenol Sodium Drugs by Country
6.1 Europe Epoprostenol Sodium Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Epoprostenol Sodium Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Epoprostenol Sodium Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
6.3 UK Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
6.4 France Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Epoprostenol Sodium Drugs by Country
7.1 Asia-Pacific Epoprostenol Sodium Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Epoprostenol Sodium Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Epoprostenol Sodium Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
7.5 India Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
8 South America Epoprostenol Sodium Drugs by Country
8.1 South America Epoprostenol Sodium Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Epoprostenol Sodium Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Epoprostenol Sodium Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Epoprostenol Sodium Drugs by Countries
9.1 Middle East and Africa Epoprostenol Sodium Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Epoprostenol Sodium Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Epoprostenol Sodium Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
10 Global Epoprostenol Sodium Drugs Market Segment by Type
10.1 Global Epoprostenol Sodium Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Epoprostenol Sodium Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Epoprostenol Sodium Drugs Revenue and Market Share by Type (2014-2019)
10.2 0.5 mg Sales Growth and Price
10.2.1 Global 0.5 mg Sales Growth (2014-2019)
10.2.2 Global 0.5 mg Price (2014-2019)
10.3 1.5 mg Sales Growth and Price
10.3.1 Global 1.5 mg Sales Growth (2014-2019)
10.3.2 Global 1.5 mg Price (2014-2019)
11 Global Epoprostenol Sodium Drugs Market Segment by Application
11.1 Global Epoprostenol Sodium Drugs Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Clinic Sales Growth (2014-2019)
12 Epoprostenol Sodium Drugs Market Forecast (2019-2024)
12.1 Global Epoprostenol Sodium Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Epoprostenol Sodium Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Epoprostenol Sodium Drugs Market Forecast (2019-2024)
12.2.2 Europe Epoprostenol Sodium Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Epoprostenol Sodium Drugs Market Forecast (2019-2024)
12.2.4 South America Epoprostenol Sodium Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Epoprostenol Sodium Drugs Market Forecast (2019-2024)
12.3 Epoprostenol Sodium Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Epoprostenol Sodium Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Epoprostenol Sodium Drugs Market Share Forecast by Type (2019-2024)
12.4 Epoprostenol Sodium Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Epoprostenol Sodium Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Epoprostenol Sodium Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Epoprostenol Sodium Drugs Picture
Table Product Specifications of Epoprostenol Sodium Drugs
Figure Global Sales Market Share of Epoprostenol Sodium Drugs by Types in 2018
Table Epoprostenol Sodium Drugs Types for Major Manufacturers
Figure 0.5 mg Picture
Figure 1.5 mg Picture
Figure Epoprostenol Sodium Drugs Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure United States Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Epoprostenol Sodium Drugs Revenue (Value) and Growth Rate (2014-2024)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Epoprostenol Sodium Drugs Type and Applications
Table GSK Epoprostenol Sodium Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Epoprostenol Sodium Drugs Type and Applications
Table Teva Epoprostenol Sodium Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Epoprostenol Sodium Drugs Sales by Manufacturer (2017-2018)
Figure Global Epoprostenol Sodium Drugs Sales Market Share by Manufacturer in 2017
Figure Global Epoprostenol Sodium Drugs Sales Market Share by Manufacturer in 2018
Table Global Epoprostenol Sodium Drugs Revenue by Manufacturer (2017-2018)
Figure Global Epoprostenol Sodium Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Epoprostenol Sodium Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Epoprostenol Sodium Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Epoprostenol Sodium Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Global Epoprostenol Sodium Drugs Revenue and Growth Rate (2014-2019)
Table Global Epoprostenol Sodium Drugs Sales by Regions (2014-2019)
Table Global Epoprostenol Sodium Drugs Sales Market Share by Regions (2014-2019)
Table Global Epoprostenol Sodium Drugs Revenue by Regions (2014-2019)
Figure Global Epoprostenol Sodium Drugs Revenue Market Share by Regions in 2014
Figure Global Epoprostenol Sodium Drugs Revenue Market Share by Regions in 2018
Figure North America Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Europe Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure South America Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure North America Epoprostenol Sodium Drugs Revenue and Growth Rate (2014-2019)
Table North America Epoprostenol Sodium Drugs Sales by Countries (2014-2019)
Table North America Epoprostenol Sodium Drugs Sales Market Share by Countries (2014-2019)
Figure North America Epoprostenol Sodium Drugs Sales Market Share by Countries in 2014
Figure North America Epoprostenol Sodium Drugs Sales Market Share by Countries in 2018
Table North America Epoprostenol Sodium Drugs Revenue by Countries (2014-2019)
Table North America Epoprostenol Sodium Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Epoprostenol Sodium Drugs Revenue Market Share by Countries in 2014
Figure North America Epoprostenol Sodium Drugs Revenue Market Share by Countries in 2018
Figure United States Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Canada Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Europe Epoprostenol Sodium Drugs Revenue and Growth Rate (2014-2019)
Table Europe Epoprostenol Sodium Drugs Sales by Countries (2014-2019)
Table Europe Epoprostenol Sodium Drugs Sales Market Share by Countries (2014-2019)
Table Europe Epoprostenol Sodium Drugs Revenue by Countries (2014-2019)
Figure Europe Epoprostenol Sodium Drugs Revenue Market Share by Countries in 2017
Figure Europe Epoprostenol Sodium Drugs Revenue Market Share by Countries in 2018
Figure Germany Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure UK Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure France Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Russia Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Italy Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Epoprostenol Sodium Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Epoprostenol Sodium Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Epoprostenol Sodium Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Epoprostenol Sodium Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Epoprostenol Sodium Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Epoprostenol Sodium Drugs Revenue Market Share by Countries 2018
Figure China Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Japan Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Korea Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure India Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure South America Epoprostenol Sodium Drugs Revenue and Growth Rate (2014-2019)
Table South America Epoprostenol Sodium Drugs Sales by Countries (2014-2019)
Table South America Epoprostenol Sodium Drugs Sales Market Share by Countries (2014-2019)
Figure South America Epoprostenol Sodium Drugs Sales Market Share by Countries in 2018
Table South America Epoprostenol Sodium Drugs Revenue by Countries (2014-2019)
Table South America Epoprostenol Sodium Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Epoprostenol Sodium Drugs Revenue Market Share by Countries in 2018
Figure Brazil Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Epoprostenol Sodium Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Epoprostenol Sodium Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Epoprostenol Sodium Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Epoprostenol Sodium Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Epoprostenol Sodium Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Epoprostenol Sodium Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Epoprostenol Sodium Drugs Revenue Market Share by Countries in 2014
Figure Middle East and Africa Epoprostenol Sodium Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure UAE Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Epoprostenol Sodium Drugs Sales and Growth Rate (2014-2019)
Table Global Epoprostenol Sodium Drugs Sales by Type (2014-2019)
Table Global Epoprostenol Sodium Drugs Sales Share by Type (2014-2019)
Table Global Epoprostenol Sodium Drugs Revenue by Type (2014-2019)
Table Global Epoprostenol Sodium Drugs Revenue Share by Type (2014-2019)
Figure Global 0.5 mg Sales Growth (2014-2019)
Figure Global 0.5 mg Price (2014-2019)
Figure Global 1.5 mg Sales Growth (2014-2019)
Figure Global 1.5 mg Price (2014-2019)
Table Global Epoprostenol Sodium Drugs Sales by Application (2014-2019)
Table Global Epoprostenol Sodium Drugs Sales Share by Application (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Epoprostenol Sodium Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Epoprostenol Sodium Drugs Sales Forecast by Regions (2019-2024)
Table Global Epoprostenol Sodium Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Epoprostenol Sodium Drugs Market Forecast (2019-2024)
Figure Europe Sales Epoprostenol Sodium Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Epoprostenol Sodium Drugs Market Forecast (2019-2024)
Figure South America Sales Epoprostenol Sodium Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Epoprostenol Sodium Drugs Market Forecast (2019-2024)
Table Global Epoprostenol Sodium Drugs Sales Forecast by Type (2019-2024)
Table Global Epoprostenol Sodium Drugs Market Share Forecast by Type (2019-2024)
Table Global Epoprostenol Sodium Drugs Sales Forecast by Application (2019-2024)
Table Global Epoprostenol Sodium Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界のエポプロステノールナトリウムFDF市場予測（～2024年） Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation. Scope of the Report: The worldwide market for Epoprostenol Sodium FDF is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in…- 世界のベラプロストナトリウム市場予測（～2024年） Beraprost sodium (beraprost) is a stable, orally active prostacyclin analogue with vasodilatory, antiplatelet and cytoprotective effects. Scope of the Report: The worldwide market for Beraprost Sodium is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in…
- 世界のイロプロスト薬市場予測（～2024年） Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. Scope of the Report: The worldwide market for Iloprost Drugs is expected to grow at a CAGR of …
- 世界の院内感染肺炎薬パイプライン分析市場予測（～2024年） Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being mu…
- 世界の紫斑療法薬市場予測（～2024年） Purpura is one of the common hemorrhagic diseases in children, which is characterized by blood spillage under skin and mucous membrane, petechiae and pressure stasis Scope of the Report: The worldwide market for Purpura Therapy Drugs is expected to grow at a CAGR of roughly xx% over the next five ye…